Target intelligence / Profile preview

AIDA pseudogene 3 (AIDAP3)

Target
AIDAP3
Molecular classification
Other (Pseudogene)
01

Overview

AIDA pseudogene 3 (AIDAP3) is annotated as a **pseudogene** in the human genome, indicating it is a DNA sequence similar to a known gene (in this case likely related to AIDA, the Axin Interactor, Dorsalization Associated gene), but considered non-functional due to sequence mutations preventing the production of a complete, active protein. Pseudogenes can sometimes regulate gene expression at the RNA level or act as "miRNA decoys," but there is currently no functional or disease relevance described for AIDAP3. It is not a receptor, enzyme, transporter, or other canonical drug target class. Its inclusion as a therapeutic target is therefore considered **incorrect**. - The entry may be **misspelled, misclassified, or not relevant** as a target for drug discovery or development, since pseudogenes generally lack protein-coding function and are not recognized as actionable therapeutic targets. - If you intended to inquire about the protein-coding gene **AIDA (Axin interactor, dorsalization associated)**, refer instead to that entry, which encodes a cytoplasmic protein involved in signaling, but not to "AIDA pseudogene 3".

02

Mechanism of action

None

03

Biological functions

Other (No confirmed function; pseudogenes can sometimes act as regulators but there is no evidence for *AIDAP3*)
04

Disease associations

Other (No specific disease involvement or association reported for this pseudogene)

Beyond the preview

Go deeper on AIDA pseudogene 3 (AIDAP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AIDA pseudogene 3 (AIDAP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call